enVVeno Medical Corporation
NVNO
$0.9381
-$0.0308-3.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.99% | 3.55% | 7.22% | 11.68% | 18.08% |
| Total Depreciation and Amortization | -8.38% | -7.62% | -3.30% | -0.37% | 2.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.66% | -8.10% | -11.95% | -22.92% | -37.95% |
| Change in Net Operating Assets | 216.71% | -2,244.44% | 147.08% | -223.66% | -295.15% |
| Cash from Operations | -2.83% | -0.04% | 10.71% | 5.83% | 7.60% |
| Capital Expenditure | 41.94% | 28.95% | -12.12% | 2.63% | 36.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 127.88% | 151.60% | 117.51% | -149.00% | -183.90% |
| Cash from Investing | 127.65% | 151.05% | 116.97% | -149.28% | -184.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.40% | -47.40% | -47.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.40% | -47.40% | -47.12% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.60% | 1,419.51% | -99.57% | 532.33% | 46.42% |